Thymectomy — a surgery to remove the thymus gland — can help keep generalized myasthenia gravis (gMG) under control while decreasing the need for immunosuppressive medications in both younger and older patients without a thymus tumor, a study found. “These findings provide some support to the use of…
News
One year of treatment with Ultomiris (ravulizumab-cwvz) was associated with reduced fatigue and improved quality of life for three older adults with generalized myasthenia gravis (gMG), according to a small study in Italy. While all three patients experienced less muscle weakness and fewer daily struggles, changes in cognitive…
Mindy Henderson has spent much of her life challenging the limits others have placed on her. When she was diagnosed with spinal muscular atrophy (SMA) — a genetic condition that causes muscles to weaken over time — as an infant, doctors told her parents that she might not live long…
Measuring the percentage of CD3-positive T cells in the blood after thymectomy, or surgical removal of the thymus, may help identify recurrence risk in people with myasthenia gravis (MG) who do not have a thymoma, or thymus tumor, a study suggests. Data from 275 patients showed that those…
The investigational CAR T-cell therapy KYV-101, or mivocabtagene autoleucel (miv-cel), improves muscle strength and daily functioning in people with hard-to-treat generalized myasthenia gravis (gMG), with benefits lasting for up to two years after dosing. That’s according to data from three patients with self-reactive antibodies against acetylcholine receptors (AChR),…
Vyvgart (efgartigimod alfa) is generally well tolerated and effective for adults with generalized myasthenia gravis (gMG), regardless of the presence and type of disease-causing antibody, according to a real-world study in Japan. The treatment, which has been approved in Japan for gMG regardless of antibody status since 2022 and…
A prefilled syringe and an autoinjector used to deliver gefurulimab, an experimental therapy in late-stage development for generalized myasthenia gravis (gMG), can be safely and effectively used by most gMG patients, caregivers, and healthcare professionals. That’s according to a simulated-use study, which aims to assess if people can…
Satisfaction with treatment doesn’t necessarily affect whether people with myasthenia gravis (MG) take their medications as directed, according to a new study that surveyed nearly 100 patients at a center in China. Findings also indicate that people living with MG who are older are less likely to take their…
Researchers called for standardized guidelines for diagnosing and treating people with myasthenia gravis (MG) who test negative for typical disease-driving antibodies. A review study showed that antibody-negative MG tends to manifest earlier than antibody-positive disease, and a substantial portion of antibody-negative patients do not respond adequately to standard immune-suppressing…
Ongoing symptoms that persist despite treatment can disrupt daily life, work, and mental well-being among adults with generalized myasthenia gravis (gMG), according to the BEYOND study. When study participants rated how strongly they agreed with statements about how these ongoing symptoms affect their everyday lives, the statement — “If…
Recent Posts
- 2 strategies for treating gMG each work with 1 treatment, study finds
- When healthcare language fails myasthenia gravis patients in crisis
- Wondering if my myasthenia gravis diagnosis changed my personality
- MGFA Session 2026: CAR T-cell therapy shows promise in early gMG trial
- When I’m seeing double with MG, sometimes a little humor helps